Description:

NVCR is the ticker symbol for Neurocrine Biosciences, Inc., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on discovering and developing innovative treatments for diseases and disorders in areas of significant unmet medical need. Neurocrine Biosciences has a strong track record in neuroscience and endocrinology, with a portfolio that includes marketed products and a robust pipeline of drug candidates aimed at addressing a variety of conditions such as Parkinson’s disease, multiple endocrine neoplasia type 1 (MENX), and uterine fibroids.

Data:

Yields: